The largest database of trusted experimental protocols

17 protocols using lipofectamine

1

Characterization of NCC Phosphorylation Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
A full-length wild-type (WT) mouse NCC cDNA fragment was amplified from mouse EC RNA using RT-PCR, with a forward primer covering the start codon and a reverse primer covering the stop codon (NM_019415). Full-length cDNA subcloned into pcDNA3.1 (Invitrogen). NCC/pcDNA3.1 and empty vector were used for COS-7 cell transfection with lipofectamine (Invitrogen). Site-direct mutagenesis was performed to replace three phosphorylation sites — Thr53, Thr58, and Ser71 — or all three amino acids together located at the NH2-terminus of NCC with alanine, using the original NCC/pcDNA3.1 as a template (GenScript USA Inc., Piscataway, NJ). A full-length mouse IL18rap cDNA with a Flag tag at the COOH-terminus was subcloned to the same pcDNA3.1 expression vector (Bioclone, Inc., San Diego, CA). Human NCC cDNA was subcloned into the pCI-neo (Promega) and site-direct mutagenesis was used to generate G439S, S475C, E121D, and Q1030R mutants, followed by lipofectamine-mediated transfection into COS-7 cells.
+ Open protocol
+ Expand
2

Verification of SNHG4-miR-204-5p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The verification of the interaction between SNHG4 and miR-204-5p was performed using a dual-luciferase reporter assay. SNHG4 mutation was created using the Quick-Change Site-Directed Mutagenesis kit (Agilent Technologies, Inc.). The pRL-TK plasmid (Promega Corporation) was transfected with miR-204-5p I using Lipofectamine 3000. At 48 h post-transfection, the dual-Glo luciferase assay kit (Promega Corporation) was used to determine the relative luciferase activities of AGS and HGC-27 cells. Relative luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Characterization of NCC Phosphorylation Sites

Check if the same lab product or an alternative is used in the 5 most similar protocols
A full-length wild-type (WT) mouse NCC cDNA fragment was amplified from mouse EC RNA using RT-PCR, with a forward primer covering the start codon and a reverse primer covering the stop codon (NM_019415). Full-length cDNA subcloned into pcDNA3.1 (Invitrogen). NCC/pcDNA3.1 and empty vector were used for COS-7 cell transfection with lipofectamine (Invitrogen). Site-direct mutagenesis was performed to replace three phosphorylation sites — Thr53, Thr58, and Ser71 — or all three amino acids together located at the NH2-terminus of NCC with alanine, using the original NCC/pcDNA3.1 as a template (GenScript USA Inc., Piscataway, NJ). A full-length mouse IL18rap cDNA with a Flag tag at the COOH-terminus was subcloned to the same pcDNA3.1 expression vector (Bioclone, Inc., San Diego, CA). Human NCC cDNA was subcloned into the pCI-neo (Promega) and site-direct mutagenesis was used to generate G439S, S475C, E121D, and Q1030R mutants, followed by lipofectamine-mediated transfection into COS-7 cells.
+ Open protocol
+ Expand
4

Transient Transfection Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transient transfection of luciferase reporter plasmids was performed using lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions. Cells were plated in 12-well tissue culture plates at 2 × 105 per well for overnight. Nucleic acid-lipofectamine 2000 mixtures containing 0.5 μg of luciferase reporter vectors, 0.5 μg of pSV-β-galactosidase control vector (Promega) and 0.5 μg of expressing vectors or 40 nM siRNA were exposed to cells. After 24 h, cell lysates were harvested and assayed for the Luciferase activity assay (Promega), performed according to the protocol recommended by the supplier. To normalize the transfection efficiency, the same cell lysates were also assayed for β-galactosidase activity using the β-Galactosidase enzyme assay (Promega).
+ Open protocol
+ Expand
5

Oct4 promoter luciferase reporter assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 2 kb of Oct4 promoter was amplified and then inserted into the pGL3vector (Promega) to create a luciferase reporter construct, which was named pGL3-OCT4. E14 cells (1 × 106) were cotransfected with 500 ng of pGL3-OCT4, 2 µg of Peln1-overexpressing plasmid, and 100 ng of a Renilla luciferase expression construct pRL-TK (Promega) using Lipofectamine 3000. Luciferase activity was then measured with the dual luciferase assay system (Promega) after 48 h of transfection. Renilla luciferase activity was used as the internal control for normalization.
+ Open protocol
+ Expand
6

Zinc and Calcium Responsive Luciferase Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The construction of a wild type human G6PC2- and mouse G6pc2-luciferase fusion genes have been previously described (Boustead, et al. 2004 (link); Martin, et al. 2002 (link)). The construction of ZnT8 expression vectors and fusion genes containing cAMP and metal response elements ligated to a minimal Xenopus albumin promoter is described in the Supplemental Material. Cells were transfected with the indicated plasmids using lipofectamine (Promega) according to the manufacturer’s instructions and incubated for 18–20 hrs in the presence or absence of the indicated concentrations of ZnCl2 or CaCl2 prior to harvesting. Luciferase assays were performed using the Promega Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer’s instructions. Firefly luciferase activity directed by the various fusion gene constructs was expressed relative to protein concentration in the same sample. Each construct was analyzed in triplicate in multiple transfections, as specified in the Figure Legends.
+ Open protocol
+ Expand
7

Measuring IFN-β Transcriptional Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
DEF cells were co-transfected with 400 ng/well of pcaggs-UL47-Flag or an empty vector, 400 ng/well of reporter plasmid IFN-β-Luc, and 4 ng/well of pRL-TK (Promega, USA) using Lipofectamine 3000, and the cells were stimulated with 50 ng/ml poly(I:C) at 12 h after transfection and harvested at 24 h after stimulation. Finally, we detected the firefly luciferase activity by the dual-luciferase assay system (Promega, USA) according to the manufacturer’s recommendations. All reactions were performed in triplicate and at least three independent experiments.
+ Open protocol
+ Expand
8

Transfection of Liver Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 cells (DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) were cultured in RPMI 1640 GlutaMAX™-I supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin. Hep-3B cells (DSMZ, Braunschweig, Germany) and Huh7 cells (JCRB Cell Bank, Tokyo, Japan) were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin.
Cells were detached with TrypLE Express W/Phenol red (Life Technologies, Darmstadt, Germany). Media and additives were obtained from Gibco (Life Technologies). Cells were cultured under standard conditions at 37 °C in a humidified atmosphere supplemented with 5% CO2.
For transfection experiments, 1.5 × 105 Huh7 and Hep-3B cells, respectively, and 2 × 105 HepG2 cells were plated per well of a 12-well plate (Nunc, Langenselbold, Germany) and grown for 24 h to reach approximately 80% confluence. Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) was used to transfect the cells. Per well, 4 µL Lipofectamine, 1.6 µg plasmid DNA and 3 ng pRL-CMV Renilla luciferase control vector (Promega, Mannheim, Germany) were applied. The cells were harvested and luciferase activity was measured as described previously [24 (link)].
+ Open protocol
+ Expand
9

Transfection of NG108-15 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection of the NG108-15 cells was carried out using lipofectamine (Invitrogen) following the manufacturer's protocol. For each well (48-well tissue culture plates; 80% confluency), 0.5 μg CaV3.2 luciferase reporter plasmid, 0.0125 μg pRL-TK (Promega) and 0.5 μl lipofectamine were mixed with 25 μl serum-free medium. The mixture was incubated for 20 min at room temperature and then added to the appropriate wells. Cells were grown in serum-free culture medium at 37 °C and 5% CO2. After 16 h, the serum-free medium was replaced by serum-containing medium and the cells were used for experiments 36 h after transfection.
Renilla luciferase was used to normalize the transfection efficiency data, and a Dual Luciferase Reporter Assay System was used according to the manufacturer's specifications (Promega). Renilla and firefly luciferase activities were determined using the Glomax Luminometer (Promega). The results are given as firefly/Renilla relative light units if not indicated otherwise.
+ Open protocol
+ Expand
10

Validation of miR-199b-3p Binding Site

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CRIM1 fragments containing the binding site for miR-199b-3p were cloned into the luciferase reporter vector (Promega, WI, USA) (CRIM1 WT). Mutation (MUT) sites were also designed (CRIM1 MUT). Cells were transferred into 24-well plates at 3 × 104 cells per well. After 24 h, the cells were transiently co-transfected with 0.1 μg/well of the luciferase reporter vector (CRIM1 WT or CRIM1 MUT) and 50 nM miR-199b-3p mimic/NC mimic into SW480-CTxR/HCT116-CTxR cells using Lipofectamine® 2000 reagent for 48 h, the cells were collected to test the activities of firefly and Renilla luciferase by the Dual-Luciferase Assay System (Promega, WI, USA). Relative luciferase activity was expressed as the ratio of Renilla/firefly.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!